Tag: oral solid dosage contract manufacturing market analysis

  • Oral Solid Dosage Contract Manufacturing Outlook 2034: Key Drivers, Trends, and Market Frontiers

    Oral Solid Dosage Contract Manufacturing Outlook 2034: Key Drivers, Trends, and Market Frontiers

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Are the Projected Market Size and Growth Rates for the Oral Solid Dosage Contract Manufacturing Market From 2025 To 2029?

    In recent times, the market size for oral solid dosage contract manufacturing has witnessed significant growth. The market is expected to escalate from $39.39 billion in 2024 to $42.39 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. The historical growth of this market is contributed by factors such as increasing global population, prevalence of chronic diseases, and heightened emphasis on research and development.

    In the coming years, the market for oral solid dosage contract manufacturing is predicted to witness robust growth. It’s projected to surge to $55.81 billion by 2029, with an annual growth rate (CAGR) of 7.1%. The market expansion in the forecasted period can be ascribed to the rising trend of outsourcing by pharmaceutical firms, enhancements in drug delivery technology, and an upswing in drug development activities. Key trends anticipated during this period include progress in drug delivery methods, the adoption of 3D printing, and advancements in controlled-release technologies.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16137&type=smp

    How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theOral Solid Dosage Contract Manufacturing Market?

    The oral solid dosage contract manufacturing market’s expansion is predicted to be driven by the growing consumer demand for generic drugs. These are medicines that are interchangeable with brand-name drugs in terms of dosage, strength, safety, efficacy, quality, and usage. The increased uptake of generic drugs is the result of patents expiring, cost-saving measures, regulatory rewards, and greater access to healthcare. The manufacturing and distribution of generic drugs are greatly assisted by oral solid dosage contract manufacturing. This takes advantage of contract manufacturers’ abilities to improve their operations, decrease costs, maintain high-quality production, and get their products to market more efficiently and effectively. For example, data from the Food and Drug Administration—a federal agency in the US—suggests that 91% of all US prescriptions in 2022 were filled with generic drugs. Furthermore, the FDA has approved more than 32,000 generic drugs. Hence, the demand for generic drugs is fuelling the expansion of the oral solid dosage contract manufacturing market.

    Which Segments in the Oral Solid Dosage Contract Manufacturing Offer the Most Growth?

    The oral solid dosage contract manufacturingmarket covered in this report is segmented –

    1) By Product Type: Tablets; Capsules; Powders; Granules; Other Product Types

    2) By Service: Drug Product Development; Fill Finish Product Manufacturing; API Manufacturing; Packaging And Labelling; Other Applications

    3) By Therapeutic Area: Oncology; Cardiovascular Diseases; Metabolic Disorders; Neurological Disorders; infectious Diseases; Gastrointestinal Diseases; Other Therapeutic Areas

    4) By End User: Large Size Companies; Medium And Small Size Companies

    Subsegments:

    1) By Tablets: Compressed Tablets; Effervescent Tablets; Chewable Tablets; Coated Tablets (Enteric, Film Coated); Sustained Or Controlled Release Tablets

    2) By Capsules: Hard Gelatin Capsules; Soft Gel Capsules; Vegetarian Capsules; Liquid-Filled Capsules; Delayed Release Capsules

    3) By Powders: Powders For Oral Suspension; Powders For Direct Compression; Powders For Mixing Or Blending; Instant Dissolving Powders

    4) By Granules: Granules For Direct Compression; Granules For Tabletting; Effervescent Granules; Delayed Or Controlled Release Granules

    5) By Other Product Types: Lozenges; Oral Strips; Oral Thin Films; Effervescent Tablets Or Granules

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=16137&type=smp

    What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theOral Solid Dosage Contract Manufacturing Market?# Market?

    Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2024. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Are the Current Market Growth and Trends in the Oral Solid Dosage Contract Manufacturing Industry?

    Key players in the oral solid dosage contract manufacturing market are looking to maintain their market status by introducing advanced solutions like continuous manufacturing lines. This term refers to a production system or facility that takes advantage of uninterrupted manufacturing methodologies for the production of pharmaceuticals among other products. For example, WuXi STA, a pharmaceutical company based in China, introduced its initial continuous manufacturing line for oral solid pharmaceutical products in January 2023. This state-of-the-art facility signifies a major step forward in pharmaceutical production, employing continuous manufacturing principles to improve the efficiency, quality, and flexibility of drug manufacturing processes. This system enhances production timelines and minimizes downtime, speeding up the delivery of crucial medicines to patients.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-contract-manufacturing-global-market-report

    What Are the Key Elements That Define the Oral Solid Dosage Contract Manufacturing Market?

    Oral solid dosage contract manufacturing refers to outsourcing the production of oral solid dosage forms of pharmaceuticals to third-party manufacturers. This outsourcing strategy allows pharmaceutical companies to focus on their core activities, such as research, development, and marketing, while leveraging the expertise and capabilities of contract manufacturing organizations (CMO) to efficiently produce high-quality oral solid dosage pharmaceuticals.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16137

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Oral Solid Dosage Contract Manufacturing Market Forecast 2025-2034: Growth Dynamics, Emerging Trends, and Strategic Opportunities

    Oral Solid Dosage Contract Manufacturing Market Forecast 2025-2034: Growth Dynamics, Emerging Trends, and Strategic Opportunities

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    What External and Internal Drivers Are Contributing to the Growth of theOral Solid Dosage Contract Manufacturing Market?

    The oral solid dosage contract manufacturing market is experiencing growth due to increased demand for generic drugs. These medications are bioequivalent to branded ones and are gaining traction due to patent expirations, cost-effectiveness, regulatory incentives, and broader healthcare access. Contract manufacturing aids generic drug production through operational efficiency and quality assurance. In 2022, the U.S. FDA reported that 91% of prescriptions were filled with generics, with over 32,000 approvals granted.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16137&type=smp

    #What Growth Opportunities Will Drive the Oral Solid Dosage Contract Manufacturing Market’s CAGR Through 2034?

    The oral solid dosage contract manufacturing market grew strongly, rising from $39.39 billion in 2024 to $42.51 billion in 2025 at a CAGR of 7.9%. Growth was fueled by global population growth, chronic disease prevalence, and a stronger focus on R&D.

    The oral solid dosage contract manufacturing market is expected to reach $56.89 billion in 2029, at a CAGR of 7.6%. Growth is driven by increased outsourcing in the pharmaceutical industry, advancements in drug delivery, and growing drug development activities. Trends include advancements in drug delivery, integration of 3D printing, and controlled-release technologies.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16137

    Which Upcoming Market Trends and Innovations Are Set to Influence theOral Solid Dosage Contract Manufacturing Market’s Path Forward?

    Major companies in the oral solid dosage contract manufacturing market are concentrating on creating innovative solutions, such as continuous manufacturing lines, to maintain their market leadership. A continuous manufacturing line refers to a system that employs continuous manufacturing processes to produce pharmaceutical products. For example, WuXi STA, a China-based pharmaceutical company, launched its first continuous manufacturing line for oral solid pharmaceutical products in January 2023. This state-of-the-art facility represents a significant breakthrough in pharmaceutical production, utilizing continuous manufacturing to improve efficiency, quality, and flexibility. It also reduces production downtime and accelerates the delivery of essential medications.

    Who Are the Dominant Market Players Pushing the Boundaries of theOral Solid Dosage Contract Manufacturing Market?

    Major companies operating in the oral solid dosage contract manufacturing market are Pfizer Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Amgen Inc., Merck KGaA, Siemens Healthineers AG, Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under the CordenPharma brand, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-contract-manufacturing-global-market-report

    What Are the Core Segments of the Oral Solid Dosage Contract Manufacturing Market, and How Do They Contribute to Growth?

    The oral solid dosage contract manufacturing market covered in this report is segmented –

    1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types

    2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications

    3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas

    4) By End User: Large Size Companies, Medium And Small Size Companies

    Subsegments:

    1) By Tablets: Compressed Tablets, Effervescent Tablets, Chewable Tablets, Coated Tablets (Enteric, Film Coated), Sustained Or Controlled Release Tablets

    2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Vegetarian Capsules, Liquid-Filled Capsules, Delayed Release Capsules

    3) By Powders: Powders For Oral Suspension, Powders For Direct Compression, Powders For Mixing Or Blending, Instant Dissolving Powders

    4) By Granules: Granules For Direct Compression, Granules For Tabletting, Effervescent Granules, Delayed Or Controlled Release Granules

    5) By Other Product Types: Lozenges, Oral Strips, Oral Thin Films, Effervescent Tablets Or Granules

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=16137&type=smp

    What Regions Are Dominating the Oral Solid Dosage Contract Manufacturing Market Growth?

    Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2023. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Reports Similar to the Global Oral Solid Dosage Contract Manufacturing Market 2025, By The Business Research Company:

    Electronic Contract Manufacturing and Design Services Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/electronic-contract-manufacturing-and-design-services-global-market-report

    Fill-Finish Pharmaceutical Contract Manufacturing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/fill-finish-pharmaceutical-contract-manufacturing-global-market-report

    Food Contract Manufacturing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/food-contract-manufacturing-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Future Outlook of the Oral Solid Dosage Contract Manufacturing Market: Growth, Trends, and Emerging Opportunities Explored

    Future Outlook of the Oral Solid Dosage Contract Manufacturing Market: Growth, Trends, and Emerging Opportunities Explored

    Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

    How has the oral solid dosage contract manufacturing market size evolved in recent years?

    The market size for oral solid dosage contract manufacturing has seen significant growth in the recent past. The market is predicted to expand from $39.39 billion in 2024 to $42.51 billion by 2025 with a compound annual growth rate (CAGR) of 7.9%. This growth during the historical period can be credited to an increasing worldwide population, high incidence of chronic illnesses, and an enhanced focus on research and development.

    What are the predictions for the oral solid dosage contract manufacturing market size in the coming years?

    In the coming years, the market size for oral solid dosage contract manufacturing is anticipated to witness robust growth. The market is projected to expand to $56.89 billion by 2029, at a compound annual growth rate (CAGR) of 7.6%. This growth over the forecast period is primarily due to the escalating trend of outsourcing by pharmaceutical enterprises, improvements in drug delivery technology, and a rise in drug development activities. Upcoming trends for the forecast period encompass technological advancements in drug delivery, the incorporation of 3D printing, and developments in controlled-release technologies.

    Get your oral solid dosage contract manufacturing market report here!

    https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-contract-manufacturing-global-market-report

    What key factors are fueling the growth of the oral solid dosage contract manufacturing market?

    The uptick in demand for generic medications is projected to fuel the expansion of the oral solid dosage contract manufacturing market. These generic drugs, which are essentially equivalent to branded drugs in terms of dosage, strength, safety, performance, quality, and functionality, are becoming increasingly popular due to factors such as patent expiry, cost-saving initiatives, regulatory incentives, and broader access to healthcare services. The contract manufacturing of oral solid dosages plays a vital role in the production and distribution of these generic medications, utilising the strengths of contract manufacturers to improve operational efficiency, decrease costs, guarantee high-quality production, and quickly and effectively bring products to market. To illustrate, the US-based federal agency, the Food and Drug Administration, reported in 2022 that approximately 91% of all prescriptions in the US were supplied by generic drugs, with over 32,000 generic medications gaining FDA approval. Resultantly, this increased demand for generic drugs propels the growth of the oral solid dosage contract manufacturing market.

    How is the global oral solid dosage contract manufacturing market divided into key segments?

    The oral solid dosage contract manufacturing market covered in this report is segmented –

    1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types

    2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications

    3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas

    4) By End User: Large Size Companies, Medium And Small Size Companies

    Subsegments:

    1) By Tablets: Compressed Tablets, Effervescent Tablets, Chewable Tablets, Coated Tablets (Enteric, Film Coated), Sustained Or Controlled Release Tablets

    2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Vegetarian Capsules, Liquid-Filled Capsules, Delayed Release Capsules

    3) By Powders: Powders For Oral Suspension, Powders For Direct Compression, Powders For Mixing Or Blending, Instant Dissolving Powders

    4) By Granules: Granules For Direct Compression, Granules For Tabletting, Effervescent Granules, Delayed Or Controlled Release Granules

    5) By Other Product Types: Lozenges, Oral Strips, Oral Thin Films, Effervescent Tablets Or Granules

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16137&type=smp

    Who are the key firms paving the way for growth in the oral solid dosage contract manufacturing market?

    Major companies operating in the oral solid dosage contract manufacturing market are Pfizer Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Amgen Inc., Merck KGaA, Siemens Healthineers AG, Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under the CordenPharma brand, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation

    What are the key trends shaping the future of the oral solid dosage contract manufacturing market?

    Key players in the market for oral solid dosage contract manufacturing are striving to remain competitive by introducing innovative solutions including continuous manufacturing lines. These refer to production facilities or systems that use ongoing manufacturing procedures to create pharmaceuticals or other items. For instance, WuXi STA, a pharmaceutical firm based in China, initiated its debut continuous manufacturing line for oral solid pharmaceutical products in January 2023. This state-of-the-art facility represents a crucial progress in the production of pharmaceuticals, utilizing continuous manufacturing concepts to improve efficiency, quality and flexible manufacturing processes. This adaptability improves production schedules and cuts down on downtime, ultimately speeding up the distribution of essential drugs to patients.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16137

    What regions are contributing significantly to the growth of the oral solid dosage contract manufacturing market?

    Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2023. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Electronic Contract Manufacturing and Design Services Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/electronic-contract-manufacturing-and-design-services-global-market-report

    Fill-Finish Pharmaceutical Contract Manufacturing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/fill-finish-pharmaceutical-contract-manufacturing-global-market-report

    Food Contract Manufacturing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/food-contract-manufacturing-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Oral Solid Dosage Contract Manufacturing Market Growth Potential: Key Insights for 2024-2033

    Oral Solid Dosage Contract Manufacturing Market Growth Potential: Key Insights for 2024-2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Oral Solid Dosage Contract Manufacturing Market from 2024 to 2033?
    The oral solid dosage contract manufacturing market size has shown strong growth in recent years. It is projected to grow from $36.70 billion in 2023 to $39.39 billion in 2024, at a CAGR of 7.3%. This growth is linked to the increasing global population, prevalence of chronic diseases, and a focus on research and development.

    The oral solid dosage contract manufacturing market is expected to reach $52.94 billion in 2028 with a CAGR of 7.3%. Growth factors include increasing outsourcing by pharmaceutical companies and advancements in drug delivery technology. Key trends involve 3D printing integration and controlled-release technologies.

    Claim Your Free Sample of the Global Oral Solid Dosage Contract Manufacturing Market Report Today!
    https://www.thebusinessresearchcompany.com/sample.aspx?id=16137&type=smp

    What Key Factors Are Fueling the Growth of the Oral Solid Dosage Contract Manufacturing Market?
    The rising demand for generic drugs is expected to spur the growth of the oral solid dosage contract manufacturing market. This demand is driven by patent expirations and regulatory incentives, making generic drugs more accessible. Contract manufacturing enhances operational efficiency and reduces costs in producing generic medications. The FDA estimated that 91% of prescriptions in the U.S. were for generic drugs in 2022, with over 32,000 generic drugs approved. Thus, the demand for generic drugs is fueling the oral solid dosage contract manufacturing market.

    What Are the Major Segments of the Oral Solid Dosage Contract Manufacturing Market?
    1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types
    2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications
    3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas
    4) By End User: Large Size Companies, Medium And Small Size Companies

    What New Trends Are Transforming the Oral Solid Dosage Contract Manufacturing Market?
    Major companies in the oral solid dosage contract manufacturing market are working on innovative solutions such as continuous manufacturing lines to strengthen their market position. Continuous manufacturing lines enable more efficient production of pharmaceuticals. For instance, in January 2023, WuXi STA launched its first continuous manufacturing line for oral solid products, enhancing efficiency and quality in drug manufacturing.

    Order Now for Fast Delivery of Your Oral Solid Dosage Contract Manufacturing Market Report!
    https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-contract-manufacturing-global-market-report

    Which Regions Are Driving Growth in the Oral Solid Dosage Contract Manufacturing Market?
    Asia Pacific was the largest region in the oral solid dosage contract manufacturing market in 2023. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Oral Solid Dosage Contract Manufacturing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the oral solid dosage contract manufacturing market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Oral Solid Dosage Contract Manufacturing Market Include

    1. Oral Solid Dosage Contract Manufacturing Market Executive Summary
    2. Oral Solid Dosage Contract Manufacturing Market Segments
    3. Oral Solid Dosage Contract Manufacturing Market Size And Template Market Growth Rate
    4.  Key Oral Solid Dosage Contract Manufacturing Market Trends
    5. Major Oral Solid Dosage Contract Manufacturing Market Drivers
    ……
    25. Key Mergers And Acquisitions In The Oral Solid Dosage Contract Manufacturing Market
    26. Top Oral Solid Dosage Contract Manufacturing Companies
    27. Oral Solid Dosage Contract Manufacturing Market Opportunities And Strategies
    28. Oral Solid Dosage Contract Manufacturing Market, Conclusions And Recommendations
    29. Appendix

    Discover Related Reports by The Business Research Company:
    Electronic Contract Manufacturing and Design Services Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/electronic-contract-manufacturing-and-design-services-global-market-report

    Food Contract Manufacturing Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/food-contract-manufacturing-global-market-report

    Medical Device Contract Manufacturing Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/medical-device-contract-manufacturing-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • How Is The Oral Solid Dosage Contract Manufacturing Market Expected To Grow Through 2024-2033

    How Is The Oral Solid Dosage Contract Manufacturing Market Expected To Grow Through 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Oral Solid Dosage Contract Manufacturing Global Market Report 2024, the oral solid dosage contract manufacturing market is expected to show promising growth in the forecast period.

    The oral solid dosage contract manufacturing market has experienced significant growth in recent years and is poised for further expansion. As of 2023, the market size was valued at $36.70 billion and is expected to reach $39.39 billion by 2024, reflecting a compound annual growth rate (CAGR) of 7.3%. This robust growth is driven by several factors including an increasing global population, the rising prevalence of chronic diseases, and heightened focus on research and development. Looking ahead, the market is projected to grow to $52.94 billion by 2028, maintaining the same CAGR of 7.3%. The future growth can be attributed to increased outsourcing by pharmaceutical companies, advancements in drug delivery technologies, and heightened drug development activities.

    Key Drivers of Market Growth

    • Outsourcing by Pharmaceutical Companies: Many pharmaceutical companies are increasingly outsourcing their manufacturing processes to focus on core competencies, such as drug discovery and development. This trend is expected to continue, driving demand for oral solid dosage contract manufacturing.
    • Advancements in Drug Delivery Technology: Innovations in drug delivery systems, such as controlled-release technologies and 3D printing, are enhancing the efficiency and effectiveness of drug delivery, contributing to market growth.
    • Increasing Drug Development Activities: The rise in drug development activities, driven by the need for new and effective treatments, is fueling demand for contract manufacturing services.

    Rising Demand for Generic Drugs
    The demand for generic drugs is a major factor propelling the growth of the oral solid dosage contract manufacturing market. Generic drugs, which are bioequivalent to brand-name drugs, are increasingly favored due to their cost-effectiveness and patent expirations. This demand is supported by regulatory incentives and expanding healthcare access. For instance, in 2022, the FDA reported that 91% of prescriptions in the USA were filled with generic drugs. The contract manufacturing sector plays a crucial role in producing and distributing these generics by enhancing operational efficiency and reducing costs. This trend is expected to drive market growth as the industry continues to meet the rising demand for affordable medications.

    View More On The Oral Solid Dosage Contract Manufacturing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-contract-manufacturing-global-market-report

    Major Companies and Innovations

    • Innovative Manufacturing Solutions: Leading companies in the oral solid dosage contract manufacturing market are investing in innovative solutions to maintain competitiveness. For example, WuXi STA, a Chinese pharmaceutical company, launched its first continuous manufacturing line for oral solid products in January 2023. This state-of-the-art facility leverages continuous manufacturing processes to enhance production efficiency, quality, and flexibility.
    • Strategic Acquisitions: In August 2022, Catalent Inc. acquired Metrics Contract Services for $475 million, aiming to boost its capabilities in oral solid dosage forms. This acquisition highlights the trend of strategic expansions to enhance manufacturing capabilities and meet the growing demand.

    Market Segmentation
    The oral solid dosage contract manufacturing market is segmented into various categories:

    1. By Product Type: Includes tablets, capsules, powders, granules, and other types.
    2. By Service: Encompasses drug product development, fill-finish product manufacturing, API manufacturing, packaging and labeling, among others.
    3. By Therapeutic Area: Covers oncology, cardiovascular diseases, metabolic disorders, neurological disorders, infectious diseases, gastrointestinal diseases, and other areas.
    4. By End User: Differentiates between large companies and medium/small-sized companies.

    Regional Insights
    Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2023. The region’s growth is driven by its expanding pharmaceutical industry and increasing outsourcing trends.

    In conclusion, the oral solid dosage contract manufacturing market is on a strong growth trajectory, fueled by rising demand for generic drugs, technological advancements, and strategic industry developments. As pharmaceutical companies continue to seek efficient and cost-effective manufacturing solutions, the market is set to expand further in the coming years.

    Request A Sample Of The Global Oral Solid Dosage Contract Manufacturing Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=16137&type=smp